In March 23rd, the novel coronavirus pneumonia was treated by the Information Office of the State Council in Wuhan, Hubei. Qiu Haibo, vice president of CUHK affiliated to Southeast University, said that more and more traditional Chinese medicine, proprietary Chinese medicine and traditional Chinese medicine injection are using internationally recognized randomized controlled study method to evaluate their efficacy.
Qiu Haibo said that traditional Chinese medicine attaches great importance to syndrome differentiation and treatment, and it emphasizes individualization, but now we also realize that more and more traditional Chinese medicine, proprietary Chinese medicine and traditional Chinese medicine injection are using internationally recognized evidence-based medicine methods to evaluate their efficacy. For example, a strict randomized controlled study led by Academician Wang Chen and Gao runlin evaluated the treatment of influenza A (H1N1) and chronic heart failure by Jinhua Qinggan capsule and Qiliqiangxin capsule, with 410 to 526 sample sizes respectively. Moreover, a randomized controlled method was adopted, and it was observed that on the basis of standard treatment or conventional treatment, after the addition of these Chinese patent medicines, and Compared with conventional treatment, it can be seen that Jinhua Qinggan capsule of traditional Chinese medicine can significantly shorten the fever time of influenza patients, while Qiliqiangxin capsule can significantly improve the heart function of chronic heart failure. These studies have also been published internationally.
Qiu Haibo introduced that traditional Chinese medicine and Western medicine are different in treatment mode. From the perspective of Western medicine, most of the chemical drugs are single target, while traditional Chinese medicine and traditional Chinese medicine are more multi-target, like team warfare. The novel coronavirus pneumonia causes inflammation and immune imbalance, which further leads to organ damage, lung and heart damage, that is to say, the organ damage caused by virus, inflammation and immunity is all the target. Western medicine is a chemical drug, often targeted at a certain target, and Chinese medicine may be a multi target treatment, for example, the virus. Replication, regulation of inflammation and immunity, and subsequent organ damage, clotting and so on may be affected. For example, Xuebijing injection also proved to inhibit the replication of new coronavirus in vitro. Related animal experiments have also proved that it can inhibit the inflammatory storm and coagulation dysfunction. As a novel coronavirus pneumonia, Xuebijing injection is used in severe and severe treatment of new crown pneumonia and has achieved remarkable curative effect.